Lymphoma by Site — Trials

Lymphoma by Site — Trials · CancerIndex

Clinical trials

Registered studies

901 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 249
Recruiting: 133
Ph III recruiting: 7
Growth YoY: +10.6%
Industry share: 17%
Top sponsor: City of Hope Medical Center
Termination share: 33.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (131)

clinicaltrialsPublishedShowing 901–901 of 901 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00306969	Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma	completed	Phase 1 / Phase 2	18	Boston UniversityOTHER	1	Mar 27, 2006	clinicaltrials